Paige E Bolcas1, Eric B Brandt2, Zhonghua Zhang2, Jocelyn M Biagini Myers3, Brandy P Ruff2, Gurjit K Khurana Hershey4. 1. Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Immunology Graduate Program, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio. 2. Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 3. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 4. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Electronic address: Gurjit.Hershey@cchmc.org.
Abstract
BACKGROUND: Recent literature suggests that children who are vitamin D deficient are uniquely susceptible to the effects of traffic-related air pollution (TRAP) exposure. This is highly significant because large segments of the population reside in zones of high TRAP exposure. OBJECTIVE: We sought to determine whether vitamin D supplementation mitigates the effect of TRAP exposure on asthma development, asthma exacerbation, and/or airway inflammation and to determine the timing of vitamin D supplementation that confers maximal health benefit. METHODS: Using established mouse models of asthma, we examined the effect of prenatal and postnatal vitamin D supplementation on asthma development, as well as the utility of vitamin D as a treatment for established asthma in the context of diesel exhaust particle (DEP) exposure. RESULTS: DEP and allergen coexposure resulted in increased airway hyperresponsiveness (AHR) and accumulation of pathogenic TH2/TH17 cells in the lungs of vitamin D-deficient mice compared with control mice. Prenatal and postnatal vitamin D supplementation significantly attenuated the development of AHR and decreased pulmonary accumulation of TH2/TH17 cells after coexposure to TRAP and allergen but not to allergen alone. Restoration of normal vitamin D status had no effect on AHR once asthma was already established. CONCLUSIONS: Our data establish that vitamin D confers protection against asthma development specifically in the context of TRAP exposure. Although vitamin D replacement did not reverse established asthma, restoration of normal vitamin D status in early life significantly attenuated the development of AHR in the setting of DEP-exacerbated allergic asthma and reduced numbers of lung TH2/TH17 cells, which portend the development of severe asthma.
BACKGROUND: Recent literature suggests that children who are vitamin D deficient are uniquely susceptible to the effects of traffic-related air pollution (TRAP) exposure. This is highly significant because large segments of the population reside in zones of high TRAP exposure. OBJECTIVE: We sought to determine whether vitamin D supplementation mitigates the effect of TRAP exposure on asthma development, asthma exacerbation, and/or airway inflammation and to determine the timing of vitamin D supplementation that confers maximal health benefit. METHODS: Using established mouse models of asthma, we examined the effect of prenatal and postnatal vitamin D supplementation on asthma development, as well as the utility of vitamin D as a treatment for established asthma in the context of diesel exhaust particle (DEP) exposure. RESULTS: DEP and allergen coexposure resulted in increased airway hyperresponsiveness (AHR) and accumulation of pathogenic TH2/TH17 cells in the lungs of vitamin D-deficient mice compared with control mice. Prenatal and postnatal vitamin D supplementation significantly attenuated the development of AHR and decreased pulmonary accumulation of TH2/TH17 cells after coexposure to TRAP and allergen but not to allergen alone. Restoration of normal vitamin D status had no effect on AHR once asthma was already established. CONCLUSIONS: Our data establish that vitamin D confers protection against asthma development specifically in the context of TRAP exposure. Although vitamin D replacement did not reverse established asthma, restoration of normal vitamin D status in early life significantly attenuated the development of AHR in the setting of DEP-exacerbated allergic asthma and reduced numbers of lung TH2/TH17 cells, which portend the development of severe asthma.
Authors: Haixia Feng; Pengcheng Xun; Katharine Pike; Andrew K Wills; Bo L Chawes; Hans Bisgaard; Wei Cai; Yanping Wan; Ka He Journal: J Allergy Clin Immunol Date: 2016-09-14 Impact factor: 10.793
Authors: Eric B Brandt; Jocelyn M Biagini Myers; Thomas H Acciani; Patrick H Ryan; Umasundari Sivaprasad; Brandy Ruff; Grace K LeMasters; David I Bernstein; James E Lockey; Timothy D LeCras; Gurjit K Khurana Hershey Journal: J Allergy Clin Immunol Date: 2015-03-04 Impact factor: 10.793
Authors: Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver Journal: J Clin Endocrinol Metab Date: 2011-06-06 Impact factor: 5.958
Authors: Chaoyu Irvin; Iram Zafar; James Good; Donald Rollins; Christina Christianson; Magdalena M Gorska; Richard J Martin; Rafeul Alam Journal: J Allergy Clin Immunol Date: 2014-07-18 Impact factor: 10.793
Authors: Mario Castro; Tonya S King; Susan J Kunselman; Michael D Cabana; Loren Denlinger; Fernando Holguin; Shamsah D Kazani; Wendy C Moore; James Moy; Christine A Sorkness; Pedro Avila; Leonard B Bacharier; Eugene Bleecker; Homer A Boushey; James Chmiel; Anne M Fitzpatrick; Deborah Gentile; Mandeep Hundal; Elliot Israel; Monica Kraft; Jerry A Krishnan; Craig LaForce; Stephen C Lazarus; Robert Lemanske; Njira Lugogo; Richard J Martin; David T Mauger; Edward Naureckas; Stephen P Peters; Wanda Phipatanakul; Loretta G Que; Ajay Sheshadri; Lewis Smith; Julian Solway; Lisa Sullivan-Vedder; Kaharu Sumino; Michael E Wechsler; Sally Wenzel; Steven R White; E Rand Sutherland Journal: JAMA Date: 2014-05 Impact factor: 56.272
Authors: Eunsoo Kim; Astrid Bonnegarde-Bernard; Stephen O Opiyo; Marisa R Joldrichsen; Zayed Attia; Brian H Ahmer; Estelle Cormet-Boyaka; Prosper N Boyaka Journal: Mucosal Immunol Date: 2021-09-09 Impact factor: 7.313
Authors: Paul E Pfeffer; Haw Lu; Elizabeth H Mann; Yin-Huai Chen; Tzer-Ren Ho; David J Cousins; Chris Corrigan; Frank J Kelly; Ian S Mudway; Catherine M Hawrylowicz Journal: PLoS One Date: 2018-08-29 Impact factor: 3.240